Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions
Clinical trial NCT03197025 · TERMINATED
Trial details
- NCT number
- NCT03197025
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-09
- Primary completion
- 2019-05-14
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.